SCHEMBL29561494

SCHEMBL29561494

O=S(=O)(Nc1ccc(S(=O)(=O)Nc2ccccc2O)cc1)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 1/20 0.60
▸ GAA P10253 4/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ MAPT P10636 1/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ RECQL P46063 1/20 0.58
▸ GFER P55789 2/20 0.57
▸ APOBEC3G Q9HC16 1/20 0.57
▸ PGR P06401 1/20 0.57
▸ HSP90AA1 P07900 2/20 0.56
▸ HSP90AB1 P08238 2/20 0.56
▸ ERBB2 P04626 1/20 0.56
▸ UQCRB P14927 1/20 0.55
▸ HSD17B2 P37059 1/20 0.55
▸ HKDC1 Q2TB90 1/20 0.53
▸ CES1 P23141 1/20 0.53
▸ CYP3A4 P08684 4/20 0.52
▸ CYP2D6 P10635 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6275069 0.91 ACLY (0.69) ACLYGAAMEN1KMT2AMAPT
SCHEMBL29561469 0.86 PKM (0.64) MEN1KMT2APGRCES1CYP3A4
SCHEMBL3260803 0.84 GAA (0.71) GAAMEN1KMT2AMAPTMAPK1
SCHEMBL29562342 0.84 PGR (0.72) GAAMEN1KMT2APGRCES1
SCHEMBL29561466 0.83 PGR (0.57) MEN1KMT2APGRCES1CYP3A4
SCHEMBL29561400 0.83 ALDH1A1 (0.71) MEN1KMT2AMAPK1PGRCES1
SCHEMBL29561505 0.83 PGR (0.57) ACLYMEN1KMT2APGRCES1
SCHEMBL28279840 0.83 ACLY (0.64) ACLYMEN1KMT2APGR
SCHEMBL29561444 0.80 CES1 (0.81) ACLYGAAMAPTHTTPGR
SCHEMBL29561264 0.80 ACLY (0.62) ACLYGAAMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109384694-B SIRT6 small-molecule agonist and application thereof 上海爱乐维生物科技有限公司 2022-04-05 — — CN disclosed
Send feedback